Canaccord Genuity Reiterates a 'Buy' on Insulet (PODD); Mixed Results - NDI Integration Complete

Canaccord Genuity reiterates a 'Buy' on Insulet Corporation (NASDAQ: PODD) price target of $27.00.

Analyst, William J. Plovanic, said, "We maintain our rating following mixed Q4/11 results with revenues in line and LPS slightly below our and consensus estimates. We believe the company is well positioned going forward as 2012 should be a transformational year with NDI fully integrated and the global launch of its gen2 OmniPod."

For an analyst ratings summary and ratings history on Insulet Corporation click here. For more ratings news on Insulet Corporation click here.

Shares of Insulet Corporation closed at $19.88 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY): Bloom Energy Corporation (NYSE: BE); GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI; CMPO); and Insulet Corporation (NASD
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• DA Davidson Starts Everus (ECG) at Buy